Chiachen Cheng

Dr. Chiachen (Chi) Cheng, MD, FRCP(C), MPH is a Canadian psychiatrist based in Thunder Bay, Ontario.

Cheng graduated from Queen's University in 1997.¹⁾

She completed her General Psychiatry residency and Child & Adolescent Psychiatry sub-specialization at McMaster University.²⁾ She received a Masters of Public Health from Harvard University.³⁾

She subsequently received a two-year postdoctoral fellowship through the Canadian Institutes of Health Research’s Research in Addictions and Mental Health Policy and Services program.

Cheng was a member of the executive council of the Ontario Psychiatric Association in 2005.^{4) 5)}

At the time, sponsors for the OPA included AstraZeneca, Biovail, Eli Lilly, Genpharm, Lundbeckl, Organon, Shire, Novartis, Pfizer, and Wyeth (a Pfizer company).

Cheng is an assistant professor at the Northern Ontario School of Medicine.⁶⁾

Cheng is the Medical Director of Child and Adolescent Psychiatry at St Joseph’s Care Group Thunder Bay and Thunder Bay Regional Health Sciences Centre.⁷⁾

Her salary at St. Joseph's was $220,245.42 in 2019 and $252,330.60 in 2021.^{8) 9)}

She formerly worked as the medical director of the First Place Clinic and Regional Resource Centre under the Canadian Mental Health Association.¹⁰⁾

In 2012, Cheng was awarded a 3-year New Investigator Research Award from the SickKids Foundation and Canadian Institutes of Health Research (CIHR) for The NorthBEAT Project.

In 2017, Cheng served as a member of the New Investigator Program Grant Review Committee for the SickKids Foundation.¹¹⁾

Cheng is a member of the Mental Health Working Group of the Ontario COVID-19 Science Advisory Table.¹²⁾

In February 2020, Cheng received the PSI-50 Mid-Career Clinical Research Award from the PSI Foundation.¹³⁾

Cheng has co-authored research funded by the Canadian Pharmaceutical Association (CPhA, now the Canadian Pharmacists Association) and the Canadian Medical Association (CMA).¹⁴⁾